As of 2024-12-12, the Relative Valuation of WAVE Life Sciences Ltd (WVE) is (8.46) USD. This relative valuation is based on P/E multiples. With the latest stock price at 15.41 USD, the upside of WAVE Life Sciences Ltd based on Relative Valuation is -154.9%.
The range of the Relative Valuation is (3.66) - (9.27) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.7x - 9.9x | 8.6x |
| Forward P/E multiples | 3.9x - 10.4x | 9.5x |
| Fair Price | (3.66) - (9.27) | (8.46) |
| Upside | -123.8% - -160.2% | -154.9% |
| Date | P/E |
| 2024-12-10 | -16.02 |
| 2024-12-09 | -16.22 |
| 2024-12-06 | -16.34 |
| 2024-12-05 | -15.45 |
| 2024-12-04 | -15.52 |
| 2024-12-03 | -15.03 |
| 2024-12-02 | -16.34 |
| 2024-11-29 | -16.16 |
| 2024-11-27 | -16.04 |
| 2024-11-26 | -15.87 |
| 2024-11-25 | -15.94 |
| 2024-11-22 | -15.27 |
| 2024-11-21 | -15.36 |
| 2024-11-20 | -15.26 |
| 2024-11-19 | -15.21 |
| 2024-11-18 | -13.75 |
| 2024-11-15 | -14.63 |
| 2024-11-14 | -16.05 |
| 2024-11-13 | -16.79 |
| 2024-11-12 | -17.01 |
| 2024-11-11 | -17.59 |
| 2024-11-08 | -17.59 |
| 2024-11-07 | -15.87 |
| 2024-11-06 | -15.20 |
| 2024-11-05 | -14.81 |
| 2024-11-04 | -14.76 |
| 2024-11-01 | -14.80 |
| 2024-10-31 | -14.67 |
| 2024-10-30 | -15.33 |
| 2024-10-29 | -15.84 |
| 2024-10-28 | -16.04 |
| 2024-10-25 | -15.46 |
| 2024-10-24 | -15.86 |
| 2024-10-23 | -15.70 |
| 2024-10-22 | -15.87 |
| 2024-10-21 | -16.17 |
| 2024-10-18 | -16.38 |
| 2024-10-17 | -15.64 |
| 2024-10-16 | -15.95 |
| 2024-10-15 | -9.16 |
| 2024-10-14 | -9.34 |
| 2024-10-11 | -9.21 |
| 2024-10-10 | -8.84 |
| 2024-10-09 | -9.00 |
| 2024-10-08 | -8.56 |
| 2024-10-07 | -8.60 |
| 2024-10-04 | -9.00 |
| 2024-10-03 | -9.10 |
| 2024-10-02 | -9.45 |
| 2024-10-01 | -8.88 |